Investigation of Anti-Tumor Effects of an MLK1 Inhibitor in Prostate and Pancreatic Cancers

SIMPLE SUMMARY: Both prostate and pancreatic cancers are ranked in the top five leading causes of cancer death in American. In prostate cancer, the mainstay of therapeutic approaches is inhibition of the androgen receptor; however, resistance occurs within two years. In pancreatic cancer, there is n...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Yu-Ching, Hsu, Kai-Cheng, Lin, Tony-Eight, Zechner, Dietmar, Hsu, Sung-Po, Tsai, Yuan-Chin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389662/
https://www.ncbi.nlm.nih.gov/pubmed/34439974
http://dx.doi.org/10.3390/biology10080742

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389662/
https://www.ncbi.nlm.nih.gov/pubmed/34439974
http://dx.doi.org/10.3390/biology10080742

Ejemplares similares